Tiziana Life Sciences – Agreement with STC Biologics June 29, 2020 – Posted in: Tiziana Life Sciences (TILS)

Monday 29th June, 2020 Tiziana Life Sciences plc (“Tiziana” or the “Company”) Agreement with STC Biologics Tiziana Life Sciences Announces Agreement with STC Biologics for GMP Manufacturing of an anti-Interleukin-6-Receptor Monoclonal Antibody for Clinical Studies in Patients with COVID-19. ·     This proprietary inhalation technology for direct delivery of mAbs or other small molecule drugs such as Remdesivir® (Roche) to lungs could potentially be a transformational therapy for developing a rapid treatment for COVID-19 New York/London – 29…

Continue reading